{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:56:49Z","timestamp":1781629009491,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Placebo and nocebo effects, beneficial or adverse responses shaped by patient expectations, modulate perioperative outcomes including pain, opioid requirement, recovery, and complication risk. Although harnessing these mechanisms may improve patient care, their routine use by anesthesiologists remain unexplored. This study systematically assessed anesthesiologists\u2019 knowledge, perceived relevance, and clinical use of placebo and nocebo effects, to identify educational needs and opportunities for enhanced patient care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An observational cross-sectional online survey, was conducted in April-May 2024 among German-speaking anesthesiologists, covering diverse clinical settings and career stages. The questionnaire evaluated theoretical knowledge, perceived relevance, clinical application, attitudes toward placebo interventions and feasibility of specific strategies to enhance placebo responses and minimize nocebo effects in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 650 respondents (436 complete), self-reported knowledge of placebo effects was moderate (median\u2009=\u20096; 0\u201310), and lower for nocebo effects (median\u2009=\u20095;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Placebo mechanisms were deemed most clinically relevant in pain management (78%) and palliative care (82%). While 72% considered the use of placebo effects as acceptable and 18% essential, only 35% reported deliberate application of placebo knowledge, and 23% used nocebo mitigation strategies. Contrastingly, 92% routinely employed communication strategies to shape expectations. Placebo utilization included open-label (27%), impure (e.g., subtherapeutic analgesics; 58%), and deceptive placebos (48%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Anesthesiologists frequently integrate expectation-based interventions widely, however gaps in theoretical knowledge and deliberate systematic application remain, particularly regarding nocebo effects. Targeted education and evidence-based guidelines may foster ethical, systematic integration of placebo and nocebo effects in perioperative care and improve patient care and safety in anesthesiology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12871-025-03579-w","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T12:43:55Z","timestamp":1767617035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding and leveraging placebo and nocebo effects in perioperative care: a cross-sectional survey of German-speaking anesthesiologists"],"prefix":"10.1186","volume":"26","author":[{"given":"Johannes","family":"Wessels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Jan","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Foerster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Erlenwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Sondermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Elsenbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Aulenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"1","key":"3579_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12916-016-0767-3","volume":"15","author":"W Rief","year":"2017","unstructured":"Rief W, Shedden-Mora MC, Laferton JAC, et al. Preoperative optimization of patient expectations improves long-term outcome in heart surgery patients: results of the randomized controlled PSY-HEART trial. BMC Med. 2017;15(1):4. https:\/\/doi.org\/10.1186\/s12916-016-0767-3.","journal-title":"BMC Med"},{"key":"3579_CR2","doi-asserted-by":"publisher","unstructured":"Laferton JAC, Rief W, Shedden-Mora M. Improving patients\u2019 treatment expectations. JAMA Published Online June. 2025;4. https:\/\/doi.org\/10.1001\/jama.2025.6261.","DOI":"10.1001\/jama.2025.6261"},{"issue":"70","key":"3579_CR3","doi-asserted-by":"publisher","first-page":"70ra14","DOI":"10.1126\/scitranslmed.3001244","volume":"3","author":"U Bingel","year":"2011","unstructured":"Bingel U, Wanigasekera V, Wiech K, et al. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med. 2011;3(70):70ra14. https:\/\/doi.org\/10.1126\/scitranslmed.3001244.","journal-title":"Sci Transl Med"},{"issue":"2","key":"3579_CR4","doi-asserted-by":"publisher","first-page":"e1142","DOI":"10.1097\/PR9.0000000000001142","volume":"9","author":"EB Caliskan","year":"2024","unstructured":"Caliskan EB, Bingel U, Kunkel A. Translating knowledge on placebo and Nocebo effects into clinical practice. Pain Rep. 2024;9(2):e1142. https:\/\/doi.org\/10.1097\/PR9.0000000000001142.","journal-title":"Pain Rep"},{"issue":"4","key":"3579_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000490354","volume":"87","author":"AWM Evers","year":"2018","unstructured":"Evers AWM, Colloca L, Blease C, et al. Implications of placebo and Nocebo effects for clinical practice: expert consensus. Psychother Psychosom. 2018;87(4):204\u201310. https:\/\/doi.org\/10.1159\/000490354.","journal-title":"Psychother Psychosom"},{"key":"3579_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fphar.2019.00077","volume":"10","author":"E Hansen","year":"2019","unstructured":"Hansen E, Zech N. Nocebo effects and negative suggestions in daily clinical Practice - Forms, impact and approaches to avoid them. Front Pharmacol. 2019;10:77. https:\/\/doi.org\/10.3389\/fphar.2019.00077.","journal-title":"Front Pharmacol"},{"issue":"Suppl 1","key":"3579_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/anae.15601","volume":"77","author":"K Arrow","year":"2022","unstructured":"Arrow K, Burgoyne LL, Cyna AM. Implications of Nocebo in anaesthesia care. Anaesthesia. 2022;77(Suppl 1):11\u201320. https:\/\/doi.org\/10.1111\/anae.15601.","journal-title":"Anaesthesia"},{"issue":"4","key":"3579_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.pain.2013.02.002","volume":"154","author":"L Colloca","year":"2013","unstructured":"Colloca L, Klinger R, Flor H, Bingel U. Placebo analgesia: psychological and Neurobiological mechanisms. Pain. 2013;154(4):511. https:\/\/doi.org\/10.1016\/j.pain.2013.02.002.","journal-title":"Pain"},{"issue":"1\u20132","key":"3579_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pain.2005.08.027","volume":"120","author":"U Bingel","year":"2006","unstructured":"Bingel U, Lorenz J, Schoell E, Weiller C, B\u00fcchel C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain. 2006;120(1\u20132):8. https:\/\/doi.org\/10.1016\/j.pain.2005.08.027.","journal-title":"Pain"},{"issue":"4","key":"3579_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.neuron.2009.07.014","volume":"63","author":"F Eippert","year":"2009","unstructured":"Eippert F, Bingel U, Schoell ED, et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron. 2009;63(4):533\u201343. https:\/\/doi.org\/10.1016\/j.neuron.2009.07.014.","journal-title":"Neuron"},{"issue":"5","key":"3579_CR11","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/j.pain.0000000000002791","volume":"164","author":"F Benedetti","year":"2023","unstructured":"Benedetti F, Shaibani A, Arduino C, Thoen W. Open-label nondeceptive placebo analgesia is blocked by the opioid antagonist Naloxone. Pain. 2023;164(5):984\u201390. https:\/\/doi.org\/10.1097\/j.pain.0000000000002791.","journal-title":"Pain"},{"issue":"2","key":"3579_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/s0301-0082(97)00006-3","volume":"52","author":"F Benedetti","year":"1997","unstructured":"Benedetti F, Amanzio M. The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin. Prog Neurobiol. 1997;52(2):109\u201325. https:\/\/doi.org\/10.1016\/s0301-0082(97)00006-3.","journal-title":"Prog Neurobiol"},{"issue":"2","key":"3579_CR13","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1097\/PR9.0000000000000585","volume":"2","author":"M Blasini","year":"2017","unstructured":"Blasini M, Corsi N, Klinger R, Colloca L. Nocebo and pain: an overview of the Psychoneurobiological mechanisms. Pain Rep. 2017;2(2):e585. https:\/\/doi.org\/10.1097\/PR9.0000000000000585.","journal-title":"Pain Rep"},{"issue":"1","key":"3579_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1056\/NEJMp1504023","volume":"373","author":"TJ Kaptchuk","year":"2015","unstructured":"Kaptchuk TJ, Miller FG. Placebo effects in medicine. N Engl J Med. 2015;373(1):8\u20139. https:\/\/doi.org\/10.1056\/NEJMp1504023.","journal-title":"N Engl J Med"},{"issue":"11","key":"3579_CR15","doi-asserted-by":"publisher","first-page":"CD011284","DOI":"10.1002\/14651858.CD011284.pub2","volume":"2019","author":"JA Hayden","year":"2019","unstructured":"Hayden JA, Wilson MN, Riley RD, Iles R, Pincus T, Ogilvie R. Individual recovery expectations and prognosis of outcomes in non-specific low back pain: prognostic factor review. Cochrane Database Syst Rev. 2019;2019(11):CD011284. https:\/\/doi.org\/10.1002\/14651858.CD011284.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"3579_CR16","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1097\/j.pain.0000000000002185","volume":"162","author":"KM Flowers","year":"2021","unstructured":"Flowers KM, Patton ME, Hruschak VJ, et al. Conditioned open-label placebo for opioid reduction after spine surgery: a randomized controlled trial. Pain. 2021;162(6):1828\u201339. https:\/\/doi.org\/10.1097\/j.pain.0000000000002185.","journal-title":"Pain"},{"key":"3579_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s12916-022-02638-0","volume":"20","author":"J Stuhlreyer","year":"2022","unstructured":"Stuhlreyer J, Roder C, Krug F, Z\u00f6llner C, Flor H, Klinger R. A digital application and augmented physician rounds reduce postoperative pain and opioid consumption after primary total knee replacement (TKR): a randomized clinical trial. BMC Med. 2022;20:469. https:\/\/doi.org\/10.1186\/s12916-022-02638-0.","journal-title":"BMC Med"},{"issue":"12","key":"3579_CR18","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1097\/j.pain.0000000000000700","volume":"157","author":"C Carvalho","year":"2016","unstructured":"Carvalho C, Caetano JM, Cunha L, Rebouta P, Kaptchuk TJ, Kirsch I. Open-label placebo treatment in chronic low back pain: a randomized controlled trial. Pain. 2016;157(12):2766\u201372. https:\/\/doi.org\/10.1097\/j.pain.0000000000000700.","journal-title":"Pain"},{"key":"3579_CR19","doi-asserted-by":"publisher","unstructured":"Elvir-Lazo OL, White PF, Yumul R, Cruz Eng H. Management strategies for the treatment and prevention of postoperative\/postdischarge nausea and vomiting: an updated review. F1000Research. 2020;9. https:\/\/doi.org\/10.12688\/f1000research.21832.1. F1000 Faculty Rev-983.","DOI":"10.12688\/f1000research.21832.1"},{"key":"3579_CR20","doi-asserted-by":"publisher","first-page":"m4284","DOI":"10.1136\/bmj.m4284","volume":"371","author":"H Nowak","year":"2020","unstructured":"Nowak H, Zech N, Asmussen S, et al. Effect of therapeutic suggestions during general anaesthesia on postoperative pain and opioid use: multicentre randomised controlled trial. BMJ. 2020;371:m4284. https:\/\/doi.org\/10.1136\/bmj.m4284.","journal-title":"BMJ"},{"issue":"3","key":"3579_CR21","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1213\/ANE.0b013e3181cc5727","volume":"110","author":"D Varelmann","year":"2010","unstructured":"Varelmann D, Pancaro C, Cappiello EC, Camann WR. Nocebo-induced hyperalgesia during local anesthetic injection. Anesth Analg. 2010;110(3):868\u201370. https:\/\/doi.org\/10.1213\/ANE.0b013e3181cc5727.","journal-title":"Anesth Analg"},{"issue":"3","key":"3579_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.bja.2019.11.020","volume":"124","author":"N Fusco","year":"2020","unstructured":"Fusco N, Bernard F, Roelants F, et al. Hypnosis and communication reduce pain and anxiety in peripheral intravenous cannulation: effect of Language and confusion on pain during peripheral intravenous catheterization (KTHYPE), a multicentre randomised trial. Br J Anaesth. 2020;124(3):292\u20138. https:\/\/doi.org\/10.1016\/j.bja.2019.11.020.","journal-title":"Br J Anaesth"},{"issue":"1\u20132","key":"3579_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.pain.2004.12.028","volume":"114","author":"EV Lang","year":"2005","unstructured":"Lang EV, Hatsiopoulou O, Koch T, et al. Can words hurt? Patient-provider interactions during invasive procedures. Pain. 2005;114(1\u20132):303\u20139. https:\/\/doi.org\/10.1016\/j.pain.2004.12.028.","journal-title":"Pain"},{"key":"3579_CR24","doi-asserted-by":"publisher","first-page":"111421","DOI":"10.1016\/j.jpsychores.2023.111421","volume":"172","author":"V Faria","year":"2023","unstructured":"Faria V, Talbert C, Goturi N, et al. Placebos in pediatrics: A cross-sectional survey investigating physicians\u2019 perspectives. J Psychosom Res. 2023;172:111421. https:\/\/doi.org\/10.1016\/j.jpsychores.2023.111421.","journal-title":"J Psychosom Res"},{"issue":"10","key":"3579_CR25","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1111\/jdv.19258","volume":"37","author":"F Krefting","year":"2023","unstructured":"Krefting F, H\u00f6lsken S, Benson S, Schedlowski M, Sondermann W. How familiar are German dermatologists with placebo and Nocebo effects and to what extent are these targeted in clinical practice: A survey within the dermatological community. J Eur Acad Dermatol Venereol. 2023;37(10):2133\u201341. https:\/\/doi.org\/10.1111\/jdv.19258.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"3579_CR26","doi-asserted-by":"publisher","first-page":"e58247","DOI":"10.1371\/journal.pone.0058247","volume":"8","author":"J Howick","year":"2013","unstructured":"Howick J, Bishop FL, Heneghan C, et al. Placebo use in the united kingdom: results from a National survey of primary care practitioners. PLoS ONE. 2013;8(3):e58247. https:\/\/doi.org\/10.1371\/journal.pone.0058247.","journal-title":"PLoS ONE"},{"issue":"10","key":"3579_CR27","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1007\/s11606-021-06737-1","volume":"36","author":"A Sharma","year":"2021","unstructured":"Sharma A, Minh Duc NT, Luu Lam Thang T, et al. A Consensus-Based checklist for reporting of survey studies (CROSS). J Gen Intern Med. 2021;36(10):3179\u201387. https:\/\/doi.org\/10.1007\/s11606-021-06737-1.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"3579_CR28","doi-asserted-by":"publisher","first-page":"e0178719","DOI":"10.1371\/journal.pone.0178719","volume":"12","author":"L Kampermann","year":"2017","unstructured":"Kampermann L, Nestoriuc Y, Shedden-Mora MC. Physicians\u2019 beliefs about placebo and Nocebo effects in antidepressants - an online survey among German practitioners. PLoS ONE. 2017;12(5):e0178719. https:\/\/doi.org\/10.1371\/journal.pone.0178719.","journal-title":"PLoS ONE"},{"key":"3579_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1146\/annurev-psych-010418-102907","volume":"70","author":"KJ Petrie","year":"2019","unstructured":"Petrie KJ, Rief W. Psychobiological mechanisms of placebo and Nocebo effects: pathways to improve treatments and reduce side effects. Annu Rev Psychol. 2019;70:599\u2013625. https:\/\/doi.org\/10.1146\/annurev-psych-010418-102907.","journal-title":"Annu Rev Psychol"},{"issue":"4","key":"3579_CR30","doi-asserted-by":"publisher","first-page":"Doc38","DOI":"10.3205\/zma001693","volume":"41","author":"H \u00d6hlmann","year":"2024","unstructured":"\u00d6hlmann H, Icenhour A, Elsenbruch S, Benson S. Powerful placebo: A teaching and learning concept addressing placebo and Nocebo effects in competency-based communication training. GMS J Med Educ. 2024;41(4):Doc38. https:\/\/doi.org\/10.3205\/zma001693.","journal-title":"GMS J Med Educ"},{"issue":"1","key":"3579_CR31","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1186\/s12909-024-05671-0","volume":"24","author":"J Westendorp","year":"2024","unstructured":"Westendorp J, van Vliet LM, Meeuwis SH, et al. Optimizing placebo and minimizing Nocebo effects through communication: e-learning and virtual reality training development. BMC Med Educ. 2024;24(1):707. https:\/\/doi.org\/10.1186\/s12909-024-05671-0.","journal-title":"BMC Med Educ"},{"key":"3579_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/bs.irn.2018.01.010","volume":"138","author":"S Elsenbruch","year":"2018","unstructured":"Elsenbruch S, Labrenz F. Nocebo effects and experimental models in visceral pain. Int Rev Neurobiol. 2018;138:285\u2013306. https:\/\/doi.org\/10.1016\/bs.irn.2018.01.010.","journal-title":"Int Rev Neurobiol"},{"issue":"11","key":"3579_CR33","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/anae.16391","volume":"79","author":"K El-Boghdadly","year":"2024","unstructured":"El-Boghdadly K, Levy NA, Fawcett WJ, et al. Peri-operative pain management in adults: a multidisciplinary consensus statement from the association of anaesthetists and the British pain society. Anaesthesia. 2024;79(11):1220\u201336. https:\/\/doi.org\/10.1111\/anae.16391.","journal-title":"Anaesthesia"},{"issue":"4","key":"3579_CR34","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s12529-020-09933-1","volume":"28","author":"JW Haas","year":"2021","unstructured":"Haas JW, Rief W, Doering BK. Open-Label placebo treatment: outcome expectations and general acceptance in the Lay population. Int J Behav Med. 2021;28(4):444\u201354. https:\/\/doi.org\/10.1007\/s12529-020-09933-1.","journal-title":"Int J Behav Med"},{"key":"3579_CR35","doi-asserted-by":"publisher","first-page":"1396562","DOI":"10.3389\/fpsyt.2024.1396562","volume":"15","author":"J Wessels","year":"2024","unstructured":"Wessels J, Klinger R, Benson S, et al. Preoperative anxiolysis and treatment expectation (PATE Trial): open-label placebo treatment to reduce preoperative anxiety in female patients undergoing gynecological laparoscopic surgery - study protocol for a bicentric, prospective, randomized-controlled trial. Front Psychiatry. 2024;15:1396562. https:\/\/doi.org\/10.3389\/fpsyt.2024.1396562.","journal-title":"Front Psychiatry"},{"issue":"7","key":"3579_CR36","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jama.2014.8342","volume":"312","author":"U Bingel","year":"2014","unstructured":"Bingel U, Placebo Competence Team. Avoiding Nocebo effects to optimize treatment outcome. JAMA. 2014;312(7):693\u20134. https:\/\/doi.org\/10.1001\/jama.2014.8342.","journal-title":"JAMA"},{"issue":"12","key":"3579_CR37","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1136\/medethics-2019-105893","volume":"47","author":"L Specker Sullivan","year":"2021","unstructured":"Specker Sullivan L. More than consent for ethical open-label placebo research. J Med Ethics. 2021;47(12):e7\u20137. https:\/\/doi.org\/10.1136\/medethics-2019-105893.","journal-title":"J Med Ethics"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-025-03579-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03579-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03579-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:06:48Z","timestamp":1781626008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12871-025-03579-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3579"],"URL":"https:\/\/doi.org\/10.1186\/s12871-025-03579-w","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval (Reference No. 25-12338-BO) was approved by the ethics committee of the medical faculty of the University Duisburg-Essen and the survey was conducted in compliance with the Declaration of Helsinki. Informed consent to participate was obtained from all participants (for details of the informed consent see Supplement 1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"WS received travel support for participation in congresses and \/ or (speaker) honoraria as well as research grants from medi GmbH Bayreuth, Abbvie, Almirall, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, GSK, Janssen, LEO Pharma, Lilly, Novartis, Pfizer, Sanofi Genzyme, Takeda, and UCB outside of the present publication. SB received speaker honoraria from Astra-Zeneca, Gr\u00fcnenthal AG, Gr\u00fcnenthal GmbH, Lilly, Janssen outside of the present publication, JE received travel support for participation in congresses and \/ or (speaker) honoraria from Bayer AG, Gr\u00fcnenthal, Hexal AG; Active positions in scientific societies: German Society for Anesthesiology and Intensive Care Medicine e.V.; Member of the executive committee, Section spokesperson for Pain Medicine, First spokesperson for the Scientific Working Group on Pain Medicine; German Pain Society (Member of the advisory board. All other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}